Plasmodium vivax is the most prevalent malarial species in South America and exerts a 2 substantial burden on the populations it affects. The control and eventual elimination of 3 P. vivax are global health priorities. Genomic research contributes to this objective by 4 improving our understanding of the biology of P. vivax and through the development of 5 new genetic markers that can be used to monitor efforts to reduce malaria transmission.
Introduction 30
Despite significant advancements toward malaria control and elimination, about 40% of 31 the world's population remains at risk of infection by one of the four protozoan species 32 that commonly cause the disease [1] . Among the human malarias, P. vivax is the 33 parasite with the most morbidity outside Africa [1] . P. vivax differs from the more Methods 82 Ethics statement 83 A passive surveillance study was conducted between 2011 and 2013 in outpatient clinics 84 located in Tierralta [23] . The study protocol was approved by the Institutional Review 85 Board (IRB) affiliated to the Malaria Vaccine and Drug Development Center (MVDC, 86 Cali-Colombia). Patients with malaria infections containing more than 5,000 parasites 87 per µL of blood as determined by microscopic examination of Giemsa-stained thick 88 blood smears received oral and written explanations about the study and, after 89 expressing their willingness to participate, were requested to sign an informed consent 90 (IC) previously approved by the Institutional Review Board (IRB) affiliated to the 91 MVDC. IC from each adult individual or from the parents or guardians of children 92 under 18 years of age was obtained. Individuals between 7 and 17 years old were asked 93 to sign an additional informed assent. A trained physician of the study staff completed 94 a standard clinical evaluation and a physical examination in all malaria symptomatic 95 subjects. The local health provider treated individuals as soon as the blood sample had 96 been drawn, using national antimalarial therapy protocol of the Colombian Ministry of 97 Health and Social Protection [23] . Specifically, patients infected with P. vivax were 98 treated orally with chloroquine (25 mg per kg provided in three doses) and primaquine 99 (0.25 mg per kg daily for 14 days). 100 Sample collection 101 A brief description of each patients infection status and medical history is provided in 102 S1 Table. We collected 10 mL of blood from each patient and stored each blood sample 103 in EDTA. In order to eliminate as much human DNA as possible, each sample was 104 diluted in one volume of PBS and filtered with a CF11 column (≈ 3g) that had 105 previously been rinsed with PBS. A new column was used for each 5 mL of sample. 106 Each filtered sample was centrifuged at 1,000 g for 10 minutes. The supernatant was 107 discarded and the red blood cells (RBC) were kept at -20 • C and sent to our laboratory 108 in Cali for processing. The RBCs were suspended in one volume of PBS and aliquoted 109 into 200 µL fractions. DNA was extracted from each aliquot using a PureLink Genomic 110 DNA kit (Invitrogen, USA) following the specifications provided by the manufacturer. 111 Sequencing and alignment to reference 112 Depending on the availability and quality of the sample, we used between 300 ng and 1 113 mg of DNA to construct sequencing libraries. These libraries were constructed using a 114 Kapa Biosystems DNA Library Preparation Kit (Kapa Biosystems, USA). The resulting 115 fragments were amplified in ten rounds of PCR, using a Kapa HiFi Library adjusted the raw base quality scores by running GATK's BaseRecalibrator tool, treating 129 the set of putative Single Nucleotide Variants (SNVs) identified by SAMtools 130 (0.1.18) [30] as known variants. 131 To investigate the possibility that our patient samples contain multiple distinct P. 132 vivax strains [31, 32] , we repeated this process using sequencing reads produced from a 133 known single infection. We retrieved reads from the monkey-adapted SalI strain [31] 134 from the NCBI Sequence Read Archive (accession SRS365051) We recorded the 135 frequency of bases matching the reference genome at each site for the patient-derived 136 and single lineage alignments using a custom C++ program 137 (http://dx.doi.org/10.5281/zenodo.18190) that makes use of the BamTools [33] library. 138 For each sample, we also calculated the overall proportion of all sequenced bases that 139 produced a minority allele when mapped to the reference.
140
Variant discovery 141 We called putative SNVs and small indels from the Colombian samples using the GATK 142 UnifiedGenotyper [28] . Because we were able to establish that each patient was infected 143 by a single lineage, we treated samples as haploid. Artifacts produced during the 144 sequencing and mapping of reads to the reference can lead to false positive variant 145 calls [34] . Such calls are more likely in P. vivax due the number of multi-copy gene 146 families and paralogs in this species [35] . In order to account for these potential artifacts, 147 we took a conservative approach to variant calling and removed apparently variant sites 148 that may have resulted from mis-mapped reads. After performing an exploratory 149 analysis comparing properties of our putative variants to a random sample of 100,000 150 non-variant sites, and using guidelines described by the GATK developers [29] , we 151 established the following set of criteria to identify likely false positive variants: 
Validation of variants 174
We validated our SNV calling procedure by running the steps described above on a 175 genome alignment generated from reads previously produced from the SalI strain [31] 176 Because these reads represent an independent sequencing of the same strain that was 177 used to produce the reference genome, we expect very few non-reference alleles. We also 178 tested the effect of including low-coverage samples in our variant calling pipeline by 179 repeating this procedure with the SalI alignment down-sampled to 2x coverage. We 180 further tested the validity of filtered variant sites by searching for apparently singleton 181 SNVs (those found only once in our population sample) in previously reported SNVs 182 from other studies [19, 31] .
183
Oligonucleotide primers for polymorphic microsatellites DNA 184 markers 185 We designed PCR primers for 18 of the microsatellite loci identified using the above 186 criteria. We first chose a subset of these putative microsatellites that were distributed 187 across different P. vivax chromosomes, then developed markers using two strategies.
188
First, nine loci were identified on alignments of conserved regions between the P. Colombian samples from Tierralta.
192
All the alignments were made using ClustalX v2.0.12 and Muscle as implemented in 193 SeaView v4.3.5 [37] [38] [39] . Dyes Hex and 6-FAM were used for labelling the forward 194 primers. A complete characterization of the 18 microsatellites loci and the primers we 195 used to amplify them is provided in S1 Text and S2 Table. 196 Population genetics 197 We calculatedπ and Watterson's estimator of the population mutation rateθ w for the 198 whole genome, distinct genomic features (i.e. sequences falling in exons, intron, 199 untranslated regions and intergenic regions), and in 10 kb windows across each 200 chromosome. We accounted for the varying levels of sequence coverage among our 201 samples by using missing-data estimators for these measures [40] . Rather than setting 202 an arbitrary coverage level at which a sample should be considered missing for a given 203 site, we used our data and variant calling approach to identify the number of samples 204 from which we could call a variant if it was present at each site in the genome. We first 205 created new "reference genome" sequences by switching each unambiguous base in the 206 SalI reference following Table 1 . We then called variants against these "shifted" 207 genomes using the same procedure described above (including filtering steps). At each 208 site, a sample was considered missing if no variant could be called for that sample using 209 the true reference genome or any of the shifted references. 210 We used PyBedtools [41, 42] to generate genomic windows, and extract 211 polymorphisms from various sequence classes. We used diversity statistics calculated 212 from genomic windows to identify genomic regions with unusually high or low genetic 213 diversity. Specifically, we identified windows with values in the 1st or 99th percentile of 214 either measure, having first removed windows for which less than 85% of sites were 215 callable. We discovered a region of particularly low diversity surrounding the dhps gene, 216 so focused on this gene by calculating each statistic for the set of overlapping windows, 217 each 10 kb wide and 500 bp apart from each other.
218 Table 1 . Scheme used to produced alternative reference genomes Reference A C G T
First shift T A C G Second shift G T A C Third shift C G T A

Results
219
Genome sequencing 220 We generated between 18 and 36 million paired-end reads from each sample ( Table 2) . 221 Obtaining genomic sequences from clinical isolates of P. vivax is complicated by the 222 presence of human DNA in parasite-containing blood samples. Although we took steps 223 to remove leukocytes from each of our samples, the proportion of reads that could be 224 mapped to the SalI reference genome differed markedly among samples, ranging from 225 <1%-28%. These differences were reflected in the mean sequencing coverage achieved 226 for each sample, which varies from less than one read per base in sample 500, to greater 227 than 40 reads for sample 499.
228
Despite the presence of some poorly covered samples, our mapped reads allow 229 comparison between multiple individuals for the vast majority of the P. vivax genome 230 ( Fig. 1) . Because low-coverage samples still provide valuable data for variant calling at 231 some sites and can often be reliably genotyped for those sites known to contain 232 segregating variants, we included all of our patient samples in subsequent analyses.
233
All sampled patients were infected by only one P. vivax strain
234
The presence of multiple distinct parasite lineages within a single host has presented a 235 barrier to population genetic analysis in previous whole-genome studies of P. vivax.
236
Because Plasmodium merozoites are haploid in the vertebrate host, the presence of such 237 multiple infections in a patient can be inferred by the presence of multiple alleles at 238 different loci. In the context of high-throughput sequencing, these additional alleles 239 manifest as an excess of bases with intermediate frequencies at sites in a genome 240 alignment. This result contrasts with the distribution expected from singly infected 241 patients, where only rare sequencing errors will produce minority bases [31] . We tested 242 our samples for multiple infections by comparing the distribution of minor base 243 frequencies in our alignments with the same distribution in an alignment produced from 244 a known single infection (Fig. 2) . In both the known single infection strain and our mixed infections [31] .
248
Because the shape of the distribution of minor base frequencies will be less 249 informative for samples with low coverage, we also examined the proportion of all 250 sequenced bases that were in the minority relative to other reads aligned to the same 251 site. Again, these results are similar to those from SalI ( Table 2 ). The proportion of 252 minority bases in reads produced from a known single infection was 7.3 × 10 −4 , while 253 for our data this proportion was between 7.3 × 10 −4 and 1.11 × 10 −3 . The fact that no 254 samples had the base frequency-distributions characteristic of mixed infections, and that 255 the low-coverage samples did not produce more minor bases than other samples, 256 suggests that all of our samples can be considered single infections. introduced by including these samples. 290 We identified 789 putative microsatellite loci that met our filtering criteria. To 291 demonstrate the ability of whole-genome studies to develop new markers, we designed 292 PCR primers for 18 of these loci (choosing markers that were well-spread among the 14 293 P. vivax chromosomes). We were able to generate PCR amplicons for each locus, and 16 294 were shown to be polymorphic within the validation panel, with between 2 and 4 loci 295 segregating in this population ( Table 5 ). The alleles of each locus could be determined 296 easily, as demonstrated by the electropherograms shown in S1 Fig. 297 Figure 3 . Allele sharing among P. vivax populations:. Note: Ellipses for Peruvian [18] Cambodian and Madagascan [31] populations include only those SNVs reported in the cited studies and not included in a region that was excluded in our study.
.
298
Population genetics 299
Because each of our patient samples represents a single parasite lineage, we can use 300 standard population genetic analyses to investigate the evolutionary and demographic 301 processes shaping P. vivax genomes in Colombia.
302
We calculated two measures of genetic diversity: nucleotide diversity (π) and 303 Watterson's estimator (θ w ) of the population mutation rate [43, 44] . Across the whole 304 genome, we estimateθ w to be 7.0 × 10 −4 . The estimate for nucleotide diversity is 305 slightly lower at 6.8 × 10 −4 . For both diversity measures, genetic diversity is lowest in 306 exonic regions, then increasingly higher in 3 and 5 untranslated regions of transcripts, 307 intergenic regions, and introns (Table 3) .
308
A selective sweep around dhps 309 We identified regions of the genome with unusually high or low genetic diversity in this 310 population (S3 Table) . The most striking result of this analysis is an extended region of 311 PLOS 9/26 homozygosity on chromosome 14, which includes a 10kb window with no polymorphic 312 SNVs despite having a mean of 6.35 samples contributing data. When we narrowed our 313 focus to this region by calculatingθ w in overlapping windows, we found that the 314 Dihydropteroate Synthetase gene (dhps) was at the center of this region of low diversity 315 (Fig. 4) . Although there are no polymorphisms within this region, all eight of our 316 samples contain a non-reference allele resulting from a G to C substitution in the second 317 exon of dhps. The substitution is non-synonymous and leads to the A383G amino acid 318 substitution that has been associated with sulphadoxine resistance in numerous previous 319 studies of P. vivax [45] . This pattern of low diversity surrounding a fixed substitution is 320 the classic sign of a hard selective sweep [46, 47] , in which a single mutant or migrant 321 allele is rapidly fixed by selection. No other non-reference alleles were present in the 322 dhps gene.
323
Most of the remaining genes that overlap with other high-or low-diversity windows 324 encode proteins for which there is no functional annotation. Nevertheless, the 325 high-diversity windows include antigen and surface protein genes such as msp7 and vir 326 family proteins, which are known to be under balancing selection in P. vivax [19] .
327
Because our conservative variant calling approach removed difficult-to-align multi-copy 328 gene families, it is likely we excluded other genes under balancing selection. 329 We also examined other genes thought to be involved in drug resistance in P. vivax 330 6. Alleles of the dihydrofolate reductase (dhfr ) gene are known to confer resistance to 331 pyrimethamine, a drug administrated together with sulphadoxine (SP). We did not 332 observe evidence of a selective sweep at the dhfr locus. However, all samples for which a 333 genotype could be called reliably (six of eight) have non-synonymous SNVs leading to 334 both S58R and S117N amino acid substitutions. Both of these substitutions have been 335 associated with SP resistance in P. vivax [45] . There are two distinct nucleotide 336 variants encoding the S58R substitutions in our population samples, with three 337 parasites having AGC>AGA mutations in the 58th codon, and three others having an 338 AGC>CGC mutation. We found a total of 13 additional non-synonymous variants in 339 the ATP-cassette binding proteins (pvmdr1 and PVX 124085, a homolog of P. The genetic diversity estimated from our Colombian P. vivax population is similar to, 346 though slightly lower than, estimates derived from a global sample of P. falciparum 347 (whereθ w has been estimated to be 1.03 × 10 −3 using isolates from Africa, America,
348
Asia and Oceania [48] ). Although it is well known that P. vivax is more genetically 349 diverse than P. falciparum globally, this finding is important as it demonstrates that P. 350 vivax control programs face genetically diverse populations even in relatively small 351 spatial scales in South America.
352
It is difficult to compare the genetic diversity of our sample to that of other P. vivax 353 populations. Most studies that report estimates of genetic diversity for this species are 354 focused on clinically important epitopes or a few markers. On the other hand, 
363
We can also make a crude comparison between our results and those from other 364 whole-genome studies [18, 31] by comparing the number of non-reference alleles found in 365 each population. Despite our relatively small number of well-covered samples, restricted 366 geographic range, and the conservative approach to variant calling, we detected 33,855 367 SNVs. When we apply the same masking criteria used in this study to the variants 368 reported from an unknown number of parasite lineages from Cambodia and Madagascar 369 we arrive at comparable number of SNVs (41,630 and 45,417 respectively). Our study 370 discovered considerably more variants than a recent study of P. vivax isolates from the 371 Amazon basin in Peru (10,989 variants). It is likely that this difference reflects the low 372 genetic diversity of the particular Peruvian population studied. Simply counting 373 non-reference alleles does not provide a direct comparison of genetic diversity between 374 populations, especially when the number of parasite lineages sampled in other studies is 375 not known. Nevertheless, these results demonstrate the Colombian population sampled 376 here does not contain an unusually low number of non-reference alleles as might be 377 expected from a population with low genetic diversity.
378
Comparing the whole-genome studies also highlights the degree of allele-sharing 379 among populations (Fig. 3) . Approximately two-thirds of the SNVs detected from a P. 380 vivax population in Peru were also detected in our Colombian samples, and 11,618 New World and Old World populations, although it is important to note that 384 differences between these studies may also reflect different variant calling procedures. A 385 complete understanding of the global structure of P. vivax populations, and the relative 386 diversity of populations on different continents, will require many more population 387 samples and a consistent approach to variant calling.
388
Together these findings differ substantially from the perception that South American 389 P. vivax populations in general have low diversity as a result of a simple evolutionary 390 history [19, 20] . Some populations, including the Peruvian population discussed above, 391 do indeed have low genetic diversity, which may be the result of recent local 392 introductions or expansions from a few founders following malaria control programs [50] . 393 On the other hand, the Colombian population studied here has substantial genetic 394 PLOS 11/26 diversity. It has been suggested that such diversity could be result of complex 395 demographic processes involving multiple introductions and admixture among lineages 396 in broad temporal and spatial scales [20] . A comprehensive population genomic study of 397 South America would be required to understand the extent of such genetic 398 polymorphism and the processes involved in its maintenance. Nevertheless, our results 399 demonstrate that South American P. vivax populations do not universally have low 400 genetic diversity.
401
Our heterozygosity estimates are calculated under the assumption that each sampled 402 patient was infected by a single parasite lineage. If multiple P. vivax lineages were 403 present in some patient samples our estimates may be inflated. However, we do not 404 believe this is likely. None of our samples show the excess of intermediate frequency 405 bases expected to arise from sequencing of mixed infections (Fig. 2) . Furthermore, our 406 lowest coverage samples, which would be most likely to generate extra variant calls if 407 multiple infections were present, do not produce an excess of rare bases or singletons 408 SNVs. The apparent lack of multiple infections among our patient samples may reflect 409 local conditions in Córdoba, including seasonal transmission of the disease and the 410 widespread use of primaquine, a drug that eliminates dormant infections. Indeed, three 411 of our patients are known to have received primaquine in the 12 months prior to 412 providing their sample.
413
Signatures of natural selection 414 We identified genomic windows with exceptionally high or low genetic diversity. High 415 genetic diversity may be maintained by balancing selection, while regions of low 416 diversity may be subject to strong purifying selection or be the product of recent 417 selective sweeps. The majority of genes contained within these windows encode proteins 418 for which little is known. However, some of the high diversity windows overlap with 419 antigen and surface protein genes that are thought to be subject to balancing selection 420 in P. vivax globally [19] . It is possible that genes in other windows of exceptional 421 diversity have likewise been subject to natural selection; this could be confirmed with a 422 larger population sample and thus a statistically more powerful genome scan. 423 We also looked at patterns of diversity more broadly by comparing results from 424 different genomic features. All measures of diversity were lowest in exon sequences, 425 followed by untranslated regions, intergenic spaces, and introns. This pattern, along 426 with the relative lack of non-synonymous SNVs, is consistent with earlier studies 427 demonstrating that purifying selection has a strong effect on protein coding genes in P. 428 vivax [51] . It is interesting to note that our estimates of genetic diversity were higher for 429 introns than intergenic regions. This pattern has been reported in P. falciparum [19] ; it 430 may reflect the presence of conserved, but unannotated, genes in what are currently 431 considered intergenic regions [48] .
432
Drug resistance alleles in Colombia 433 Our analysis of low diversity regions revealed a selective sweep associated with the 434 A383G allele of dhps, which has previously been associated with resistance to 435 Sulfadoxine [45] . Although resistance to SP treatment, and indeed resistance mediated 436 by this particular mutation, is a well known phenomenon, this result is interesting for 437 two reasons. First, by identifying a selective sweep around this mutation we are able to 438 demonstrate that SP resistance has arisen within Colombia via the rapid fixation of a 439 single allele. This finding, combined with the fact that another dhps allele (A385G) is 440 most commonly associated with SP resistance in Madagascar [52] , French Guiana [52] , 441 India [53] , Iran [54] , Pakistan [55] , Thailand [56] and China [57] , suggests SP resistance 442
PLOS
12/26 has come about through multiple independent origins. Similar repeated evolution of 443 dhps resistant mutations has been reported in P. falciparum [58] [59] [60] [61] 444
The evolution of SP resistance is also interesting in an operational context because it 445 demonstrates that this P. vivax population has been subject to drug pressure from SP, 446 a drug that has not been part of the approved treatment for uncomplicated P. vivax 447 malaria in Colombia (where the drugs of choice are still chloroquine-primaquine 448 combination therapy). SP has been used to treat P. falciparum infections in Colombia, 449 so it is possible this selective pressure has arisen from misdiagnosis of P. vivax 450 infections or the use of SP to treat mixed P. vivax -P. falciparum infections. It is also 451 possible that poor compliance with national drug policies, including self-medication by 452 some patients with access to antifolates or the long half-life of antifolate drugs could 453 lead to P. vivax infections coming into contact with SP.
454
The region surrounding the dhfr does not show the pattern of decreased genetic 455 diversity associated with a hard selective sweep. In this case, all genotyped samples 456 have two SP-resistance alleles (S58R and S117N), with the first allele encoded by two 457 distinct SNVs. Thus, SP-resistance alleles in each gene have somewhat different 458 histories, with dhps A383G entering the population once and being rapidly driven 459 toward fixation, but dhfr resistance arising from two separate alleles that have been 460 maintained in the population. This pattern differs from the one found in P. falciparum, 461 where dhfr mutations associated with drug resistance are fixed as the result of a 462 selective sweep, whereas dhps mutations are still segregating with sensitive alleles in the 463 population [59, 61] . 464 We detected non-synonymous variants in two other genes thought to be involved 465 with drug resistance in Plasmodium species. There are eight non-synonymous variants 466 in PVX 124085. The phenotypic effects of these variants are not known, but the 467 changes to the P. falciparum ortholog of this gene have been associated with decreased 468 sensitivity of primaquine [62] and antifolate drugs [63] . This study is the third time that 469 an excess of non-synonymous mutations in this gene has been recorded from a 470 population in South America [18, 64] ; the clinical significance of this repeated finding 471 should be investigated. 472 We identified five non-synonymous mutations in pvmdr1, three of which are known 473 from populations in Asia and Madagascar [52, 65] . Mutations in the P. falciparum 474 ortholog of this gene are associated with decreased sensitivity to chloroquine, and 475 pvmdr1 variants are thus considered putative chloroquine-resistance alleles. Among the 476 variants we report, only Y976F has been associated with decreased sensitivity to 477 chloroquine (in vitro and with a modest effect size) [66] . There is little evidence for 478 drug failure with chloroquine in South America at present. Nevertheless, the presence of 479 these alleles in a South American population warrants further investigation and presents 480 an opportunity to test for an association between pvmdr1 alleles and sensitivity to the 481 drug in a clinical setting. 482 We also compared the variants we report from putative drug resistance genes with 483 those reported from another South American population in the Amazon basin of Peru 484 (Table 6 ). These populations share many alleles, including both SP resistane alleles in 485 dhfr and five amino acid substitutions in PVX 124085. In contrast, four of the five 486 variants we reported from pvmdr1 are not present in the Peruvian population and there 487 are no non-synonymous substitutions in Peruvian dhps sequences. These results 488 demonstrate the importance of local information in designing control programs, as each 489 population contains distinct drug resistance alleles that may generate distinct responses 490 to different treatments. In addition, the fact that two populations separated by a 491 considerable geographical distance, as well as by the Andes, share multiple alleles that 492 are identical by state at the nucleotide level, suggests that it is possible for drug 493 resistance alleles to spread by gene flow between distant populations in South America. 494
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Microsatellite loci for P. vivax studies in the Americas
495
Although population genomic studies offer a unique view into the biology of P.vivax, 496 smaller-scale studies that use genotypes from only a few loci will remain important in 497 malaria research. One important result from this study is a set of new microsatellite loci 498 that can be used in fine scale population genetic and molecular epidemiological studies 499 in Colombia. Microsatellite loci are particularly useful for such studies, as their 500 relatively high mutation rates can generate highly polymorphic loci. As a result, 501 population genetic signals in microsatellite loci can reflect demographic events occurring 502 at short time scales, including epidemiological events [50, 67] . These markers can also be 503 used for population assignment and in testing for multiple infections [21, 22, 68, 69] .
504
Thus far, 160 microsatellites have been found in the genome of P. vivax [22] ; however, 505 many of these loci fail to amplify in some populations [21, 22] . It is not surprising that 506 loci developed in one region are not necessarily informative in others: microsatellites 507 have complex evolutionary histories [70] and high potential for homoplasy [71] . Thus, 508 the widespread application of microsatellite loci to epidemiological problems will require 509 the development of new markers known to amplify and be polymorphic within specific 510 populations. We found 789 putatively polymorphic microsatellite loci from our 511 whole-genome sequencing, demonstrating that the 160 markers currently used in P.
512
vivax represent only a small proportion of loci available in this species. Moreover, we 513 demonstrated that the loci we detected in our whole-genome sequencing can be 514 developed into useful makers. The 18 markers we developed yield patterns of repeats 515 that are easy to score in populations in the Pacific Coast of Colombia and show high 516 levels of polymorphism. Whether these markers will be useful at broader geographic 517 scales remains to be seen, but the specific markers we developed will be useful for 518 fine-scale studies in this region, where malaria elimination is currently being considered. 519
Conclusion 520
Our results add to growing evidence that P. vivax populations are genetically diverse. 521 Even at a small spatial scale in Colombia, this P. vivax population harbors levels of 522 genetic diversity similar to a global sample of P. falciparum. The diversity we observed 523 appears to be inconsistant with demographic scenarios in which South American P. 524 vivax populations were derived from a recent introduction, possibly associated with a 525 severe population bottleneck [17, 72] . As such, our study lends further support to the 526 idea that P. vivax populations in the Americas have a more complex history than was 527 previously thought [20] .
528
Our study also demonstrates that genomic studies of natural populations of P. vivax 529 can provide insights into how parasite populations react to control strategies. 530 Specifically, we identified a selective sweep associated with resistance for SP, a drug that 531 is not used to treat P. vivax in Colombia. This resistance indicates a possible spillover 532 effect form of a drug that is primarily used to treat P. falciparum. The operational 533 consequences of these results require additional investigations. Future studies with 534 additional samples may detect additional regions under selection and thus contribute to 535 the identification of vaccine targets [73] or other clinically relevant phenotypes. Finally, 536 we used our genomic data to develop a set of microsatellite markers that are both easy 537 to genotype and known to be polymorphic within this population. These markers will 538 aid future epidemiological studies and our understanding of malaria transmission and 539 demography in Colombia.
540
Supporting Information Legends 541 S1 Text 542 Methods used for microsatellite development 543 S1 Table   544 Patient summary information.
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S2 Table   546 Characterization of 18 polymorphic P. vivax microsatellite loci. Size ranges "p5", "p10" and "p20" refer to the proportion of sites covered by at least 5, 10 and 20 reads respectively."Proportion of minority bases" refers to the proportion of mapped-reads at a given site that contained a base that made up a minor fraction of all mapped bases. 
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